{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360011145390201216.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1358/dot.2007.43.8.1067343"}}],"dc:title":[{"@value":"Recombinant human serum albumin"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380298343987344001","@type":"Researcher","foaf:name":[{"@value":"Chuang, V.T.G."}]},{"@id":"https://cir.nii.ac.jp/crid/1380298343987344000","@type":"Researcher","foaf:name":[{"@value":"Otagiri, M."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"16994019"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00257656"}],"prism:publicationName":[{"@value":"Drugs of Today"}],"dc:publisher":[{"@value":"Portico"}],"prism:publicationDate":"2007","prism:volume":"43","prism:number":"8","prism:startingPage":"547"},"reviewed":"false","createdAt":"2007-12-15","modifiedAt":"2023-05-30","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004232258812800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Human serum albumin–thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183367051392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567562406016","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679601139840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pharmaceutically Important Pre- and Posttranslational Modifications on Human Serum Albumin"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1358/dot.2007.43.8.1067343"},{"@type":"CROSSREF","@value":"10.1016/j.jconrel.2011.05.013_references_DOI_9QZCqxOdAW8QupL4WjucSEJfn5x"},{"@type":"CROSSREF","@value":"10.1038/labinvest.2011.71_references_DOI_9QZCqxOdAW8QupL4WjucSEJfn5x"},{"@type":"CROSSREF","@value":"10.1016/j.jconrel.2020.05.036_references_DOI_9QZCqxOdAW8QupL4WjucSEJfn5x"},{"@type":"CROSSREF","@value":"10.1248/bpb.32.527_references_DOI_9QZCqxOdAW8QupL4WjucSEJfn5x"}]}